PT87975A - Processo para a preparacao de novos benzotiofenos com actividade anti-alergica e de outros benzotiofenos seleccionados e de composicoes farmaceuticas uteis para o tratamento da sindrome da insuficiencia respiratoria aguda que os contem - Google Patents

Processo para a preparacao de novos benzotiofenos com actividade anti-alergica e de outros benzotiofenos seleccionados e de composicoes farmaceuticas uteis para o tratamento da sindrome da insuficiencia respiratoria aguda que os contem

Info

Publication number
PT87975A
PT87975A PT87975A PT8797588A PT87975A PT 87975 A PT87975 A PT 87975A PT 87975 A PT87975 A PT 87975A PT 8797588 A PT8797588 A PT 8797588A PT 87975 A PT87975 A PT 87975A
Authority
PT
Portugal
Prior art keywords
benzothiophenes
novel
contain
preparation
treatment
Prior art date
Application number
PT87975A
Other languages
English (en)
Other versions
PT87975B (pt
Inventor
David Thomas Connor
Roderick Joseph Sorenson
Michael David Mullican
David Orel Thueson
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT87975A publication Critical patent/PT87975A/pt
Publication of PT87975B publication Critical patent/PT87975B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT87975A 1987-07-14 1988-07-13 Processo para a preparacao de novos benzotiofenos com actividade anti-alergica e de outros benzotiofenos seleccionados e de composicoes farmaceuticas uteis para o tratamento da sindrome da insuficiencia respiratoria aguda que os contem PT87975B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7355487A 1987-07-14 1987-07-14
US19169988A 1988-05-17 1988-05-17

Publications (2)

Publication Number Publication Date
PT87975A true PT87975A (pt) 1989-06-30
PT87975B PT87975B (pt) 1995-03-01

Family

ID=26754606

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87975A PT87975B (pt) 1987-07-14 1988-07-13 Processo para a preparacao de novos benzotiofenos com actividade anti-alergica e de outros benzotiofenos seleccionados e de composicoes farmaceuticas uteis para o tratamento da sindrome da insuficiencia respiratoria aguda que os contem

Country Status (16)

Country Link
EP (1) EP0299457B1 (pt)
JP (1) JP2672980B2 (pt)
KR (1) KR970011580B1 (pt)
CN (1) CN1031084A (pt)
AT (1) ATE111908T1 (pt)
AU (1) AU605070B2 (pt)
CA (1) CA1330562C (pt)
DE (1) DE3851584T2 (pt)
DK (1) DK175933B1 (pt)
ES (1) ES2063747T3 (pt)
FI (1) FI91256C (pt)
IE (1) IE64995B1 (pt)
NO (1) NO170886C (pt)
NZ (1) NZ225378A (pt)
PH (1) PH25958A (pt)
PT (1) PT87975B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689129B1 (fr) * 1992-03-27 1995-05-12 Atochem Elf Sa Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
US5426191A (en) * 1993-12-03 1995-06-20 Warner-Lambert Company Process for the synthesis of 3-chlorobenzo[b]thiophene-2-carbonyl chlorides
US6203803B1 (en) 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
FR2719474B1 (fr) 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
FR2719476B1 (fr) * 1994-05-05 1997-05-23 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
DE19620508A1 (de) * 1996-05-22 1997-11-27 Hoechst Ag Schwefelenthaltende heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung
MXPA05012953A (es) * 2003-06-05 2006-02-13 Warner Lambert Co Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos.
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
WO2004108708A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-substituted indoles and derivatives thereof as therapeutic agents
BRPI0410913A (pt) * 2003-06-05 2006-06-27 Warner Lambert Co benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
DE602004007268D1 (de) * 2003-06-05 2007-08-09 Warner Lambert Co CYCLOALKYLSULFANYL-SUBSTITUIERTE BENZOiBöTHIOPHENE ALS THERAPEUTISCHE MITTEL
WO2005023800A1 (en) * 2003-09-04 2005-03-17 Warner-Lambert Company Llc Halo substituted benzo`b! thiophenes with pi3k inhibitory activity as therapeutic agents
FR2862645B1 (fr) * 2003-11-20 2007-06-22 Merck Sante Sas Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140785A (en) * 1978-05-08 1979-02-20 E. I. Du Pont De Nemours And Company N-(benzothienopyrazol)amide antirhinoviral agents
US4432986A (en) * 1979-06-18 1984-02-21 Riker Laboratories, Inc. Tetrazoles bonded to certain polycyclic aromatic systems and anti-allergic use thereof
EP0146243A1 (en) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase inhibitors
GB8401288D0 (en) * 1984-01-18 1984-02-22 Pfizer Ltd Therapeutic agents
GB8426474D0 (en) * 1984-10-19 1984-11-28 Ici America Inc Heterocyclic amides
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
ZA858748B (en) * 1984-12-10 1987-06-24 Warner Lambert Co Novel benzothiophenes and benzofurans having antiallergy activity
IE58555B1 (en) * 1984-12-10 1993-10-06 Warner Almbert Company Novel benzothiophenes and benzofurans having antiallergy activity
US4748183A (en) * 1986-06-13 1988-05-31 Warner-Lambert Company N-1H-tetrazol-5-yl-2-thiophene carboxamides, N-1H-tetrazol-5-yl-2-pyrrole carboxamides, N-1H-tetrazol-5-yl-2-furan carboxamides, and anti-allergic and anti-inflammatory use thereof
EP0253650A3 (en) * 1986-07-18 1989-09-13 Eli Lilly And Company Improvements relating to benzothiophene derivatives

Also Published As

Publication number Publication date
EP0299457A2 (en) 1989-01-18
FI91256C (fi) 1994-06-10
KR970011580B1 (ko) 1997-07-12
AU605070B2 (en) 1991-01-03
DK388488A (da) 1989-01-15
FI91256B (fi) 1994-02-28
PH25958A (en) 1992-01-13
AU1857788A (en) 1989-01-19
PT87975B (pt) 1995-03-01
JP2672980B2 (ja) 1997-11-05
DK175933B1 (da) 2005-07-18
IE64995B1 (en) 1995-09-20
CA1330562C (en) 1994-07-05
NO170886B (no) 1992-09-14
FI883300A0 (fi) 1988-07-11
DK388488D0 (da) 1988-07-12
DE3851584D1 (de) 1994-10-27
NO883100L (no) 1989-01-16
DE3851584T2 (de) 1995-01-26
NO170886C (no) 1992-12-23
ES2063747T3 (es) 1995-01-16
EP0299457A3 (en) 1989-07-19
CN1031084A (zh) 1989-02-15
NZ225378A (en) 1992-03-26
FI883300A (fi) 1989-01-15
IE881879L (en) 1989-01-14
JPH01110682A (ja) 1989-04-27
ATE111908T1 (de) 1994-10-15
NO883100D0 (no) 1988-07-12
KR890002129A (ko) 1989-04-08
EP0299457B1 (en) 1994-09-21

Similar Documents

Publication Publication Date Title
PT87975A (pt) Processo para a preparacao de novos benzotiofenos com actividade anti-alergica e de outros benzotiofenos seleccionados e de composicoes farmaceuticas uteis para o tratamento da sindrome da insuficiencia respiratoria aguda que os contem
PT87259A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 17-cetoesteroides apropriadas para o tratamento e a profilaxia de infeccoes retrovirais
BR8401646A (pt) Processo e dispositivo para recuperar produtos quimicos de licor de refugo da producao de polpa de madeira,primariamente do processo tipo "kraft"
PT80578B (pt) Processo de preparacao de acidos 7-amino-1-cicloporpil-6,8-di-hidro-4-oxo-3-quinolinocarboxilicos e de agentes antibacterianos que os contem
NO890408D0 (no) 3-indolpyrodruesyre-derivater og deres farmasoeytiske anvendelse.
PT89502A (pt) Processo para a preparacao de derivados de 2-(2-hidroxi-3-fenoxi-metilo e de composicoes farmaceuticas que os contem
BR8803767A (pt) Processo para esterilizacao com vapor
PT83909B (pt) Processo para a preparacao de 5-amino e 5-hidroxi-6,8-difluoroquinolonas e de composicoes farmaceuticas antibacterianas que as contem
ZA881540B (en) Use of metformin in the preparation of medicines
CY1513A (en) Benzothiphene derivatives as bronchodilators
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
PT90743A (pt) Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem
PT89145A (pt) Processo para a preparacao de derivados da manumicina e de composicoes farmaceuticas que os contem
BR8506970A (pt) Processo e aparelho para o tratamento do aparelho respiratorio
BR9007936A (pt) Processo para diagnosticar risco arterioscleroso,e processo de medicao de concentracoes de lipoproteina
BR8806062A (pt) Processo para a preparacao de uma composicao concentrada estavel,bombeavel e despejavel,processo para a preparacao de uma composicao amaciante de tecidos,composicao concentrada,e composicao para tratamento de texteis
PT95456A (pt) Processo para a preparacao de preparados de combinacao de acido acetilsalicilico e de derivados de carbaciclina com accao antitrombotica
PT87986A (pt) Processo para a preparacao de derivados de tieno-imidazol substituido e de composicoes farmaceuticas que os contem, apropriadas como agentes inibidores da secrecao do acido do estomago, para a proteccao do estomago, assim como para o tratamento de inflamacoes intestinais
PT88375A (pt) Processo para a preparacao de derivados glucosidicos da 3'-demetoxiepipodofilotoxina e de composicoes farmaceuticas que os contem
ES2014494B3 (es) Procedimiento para el tratamiento de material de fibra de celulosa coloreada
DK229984D0 (da) 4-oxothiazolidin-2-yliden-acetamid-derivater
ES2037807T3 (es) Medicamentos que contienen en combinacion interferon y 1-desoxi-piperidinosas, procedimiento para su fabricacion y su aplicacion.
IT8421046A0 (it) Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico.
PT92155A (pt) Processo para a preparacao de derivados de acidos 2-amino-carboxilicos e de composicoes farmaceuticas que os contem
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940818

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20070219